JP2008538288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008538288A5 JP2008538288A5 JP2008506408A JP2008506408A JP2008538288A5 JP 2008538288 A5 JP2008538288 A5 JP 2008538288A5 JP 2008506408 A JP2008506408 A JP 2008506408A JP 2008506408 A JP2008506408 A JP 2008506408A JP 2008538288 A5 JP2008538288 A5 JP 2008538288A5
- Authority
- JP
- Japan
- Prior art keywords
- inflammatory bowel
- bowel disease
- atcc pta
- lactobacillus reuteri
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 5
- 241000186604 Lactobacillus reuteri Species 0.000 claims 5
- 229940001882 Lactobacillus reuteri Drugs 0.000 claims 5
- 239000003636 conditioned culture media Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 206010061218 Inflammation Diseases 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 239000000969 carrier Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 241000186660 Lactobacillus Species 0.000 claims 1
- 229940039696 Lactobacillus Drugs 0.000 claims 1
- 206010068760 Ulcers Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
Claims (7)
- ラクトバチルスロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｒｅｕｔｅｒｉ）株ＡＴＣＣ ＰＴＡ−６４７５である菌株。
- 請求項１に記載の菌株の培養物由来の馴化培地を含む、炎症性腸疾患における炎症を治療するための医薬。
- ラクトバチルスロイテリ株ＡＴＣＣ ＰＴＡ−６４７５を含む、炎症性腸疾患患者に投与するための医薬。
- ラクトバチルスロイテリ株ＡＴＣＣ ＰＴＡ−６４７５の培養物由来の馴化培地を含む、炎症性腸疾患患者に投与するための医薬。
- 公知の摂取可能な担体と、ラクトバチルスロイテリ株ＡＴＣＣ ＰＴＡ−６４７５を含む、炎症性腸疾患における炎症を治療するのに有用な医薬組成物。
- 公知の摂取可能な担体と、ラクトバチルスロイテリ株ＡＴＣＣ ＰＴＡ−６４７５由来の馴化培地を含む、炎症性腸疾患における炎症を治療するのに有用な医薬組成物。
- 請求項１記載の菌株の培養物が増殖した後のラクトバチルス馴化培地中に存在する５ｋＤａのタンパク様物質を含む、潰瘍を治療するのに有効な医薬。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/107,438 US7344867B2 (en) | 2005-04-15 | 2005-04-15 | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| US11/107,438 | 2005-04-15 | ||
| PCT/SE2006/000434 WO2006110088A1 (en) | 2005-04-15 | 2006-04-12 | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008538288A JP2008538288A (ja) | 2008-10-23 |
| JP2008538288A5 true JP2008538288A5 (ja) | 2010-12-02 |
| JP4740999B2 JP4740999B2 (ja) | 2011-08-03 |
Family
ID=37087291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506408A Active JP4740999B2 (ja) | 2005-04-15 | 2006-04-12 | 哺乳類における炎症を軽減するための乳酸菌の選択及び使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7344867B2 (ja) |
| EP (1) | EP1868622B1 (ja) |
| JP (1) | JP4740999B2 (ja) |
| KR (1) | KR101042123B1 (ja) |
| CN (1) | CN101160134B (ja) |
| AU (1) | AU2006234793B2 (ja) |
| DK (1) | DK1868622T3 (ja) |
| ES (1) | ES2606765T3 (ja) |
| HK (1) | HK1115730A1 (ja) |
| HU (1) | HUE032297T2 (ja) |
| LT (1) | LT1868622T (ja) |
| MX (1) | MX2007012656A (ja) |
| PL (1) | PL1868622T3 (ja) |
| PT (1) | PT1868622T (ja) |
| RU (1) | RU2378370C2 (ja) |
| SI (1) | SI1868622T1 (ja) |
| WO (1) | WO2006110088A1 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080254011A1 (en) * | 2007-04-11 | 2008-10-16 | Peter Rothschild | Use of selected lactic acid bacteria for reducing atherosclerosis |
| US20110293710A1 (en) * | 2010-02-02 | 2011-12-01 | Delphine Saulnier | Immunomodulatory properties of lactobacillus strains |
| US8785183B2 (en) * | 2010-09-21 | 2014-07-22 | Biogaia Ab | Active plastic material in oil |
| US20130022586A1 (en) * | 2011-07-21 | 2013-01-24 | James Versalovic | Production and use of bacterial histamine |
| ES2402014B1 (es) | 2011-09-07 | 2014-02-27 | Consejo Superior De Investigaciones Científicas (Csic) | Peptido secretado por lactobacillus plantarum con función inmunomoduladora |
| JP6203816B2 (ja) | 2012-03-29 | 2017-09-27 | セラバイオーム，エルエルシー | 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤 |
| ES2847424T3 (es) | 2012-06-04 | 2021-08-03 | Biogaia Ab | Bacterias del ácido láctico para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos |
| US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| RU2692671C2 (ru) * | 2014-01-23 | 2019-06-26 | Биогайа Аб | Выбор агентов, модулирующих гастроинтестинальную боль |
| US20180104287A1 (en) * | 2015-03-26 | 2018-04-19 | Biogaia Ab | Histamine-producing bacterial strains and their use in cancer |
| US10376563B1 (en) | 2016-02-12 | 2019-08-13 | Wisconsin Alumni Research Foundation | Methods for systemically delivering polypeptides and microorganisms therefor |
| SI3442547T1 (sl) | 2016-04-15 | 2023-11-30 | Baylor College Of Medicine | Lactobacillus reuteri MM4-1A za uporabo pri zdravljenju ali preprečevanju motenj avtističnega spektra |
| KR102250597B1 (ko) | 2017-11-20 | 2021-05-11 | 경희대학교 산학협력단 | 신규 유산균 및 이의 용도 |
| CN110893195B (zh) * | 2019-09-30 | 2023-03-14 | 内蒙古伊利实业集团股份有限公司 | 一种具有缓解肠道炎症功能的副干酪乳杆菌et-22 |
| WO2021091474A1 (en) | 2019-11-08 | 2021-05-14 | Biogaia Ab | Serotonin producing bacteria |
| CN114196581B (zh) * | 2020-12-16 | 2023-06-13 | 江南大学 | 缓解高尿酸血症的罗伊氏乳杆菌ccfm1132及应用 |
| EP4175968B1 (en) | 2021-07-30 | 2024-07-03 | Helaina, Inc. | Methods and compositions for protein synthesis and secretion |
| WO2023063314A1 (ja) | 2021-10-11 | 2023-04-20 | 味の素株式会社 | 異種Ｔａｔ系タンパク質を発現するよう改変された細菌 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413960A (en) * | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| US5458875A (en) * | 1990-06-15 | 1995-10-17 | Biogaia Ab | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry |
| US5534253A (en) * | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| US5837238A (en) * | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| US20010049115A1 (en) * | 2000-01-17 | 2001-12-06 | Collins John Kevin | Vitro model for gastrointestinal inflammation |
| AU5773600A (en) * | 1999-06-30 | 2001-01-31 | Board Of Regents Of The University Of Nebraska, The | Method of isolation of regulated virulence determinants from bacterial pathogens |
| US6953574B2 (en) * | 2002-06-21 | 2005-10-11 | Technology Commercialization, Inc. | Method for producing a fermented hydrolyzed medium containing microorganisms |
| US7105336B2 (en) | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
-
2005
- 2005-04-15 US US11/107,438 patent/US7344867B2/en active Active
-
2006
- 2006-04-12 LT LTEP06733290.8T patent/LT1868622T/lt unknown
- 2006-04-12 CN CN2006800120990A patent/CN101160134B/zh active Active
- 2006-04-12 EP EP06733290.8A patent/EP1868622B1/en active Active
- 2006-04-12 ES ES06733290.8T patent/ES2606765T3/es active Active
- 2006-04-12 HU HUE06733290A patent/HUE032297T2/en unknown
- 2006-04-12 PL PL06733290T patent/PL1868622T3/pl unknown
- 2006-04-12 DK DK06733290.8T patent/DK1868622T3/en active
- 2006-04-12 PT PT67332908T patent/PT1868622T/pt unknown
- 2006-04-12 JP JP2008506408A patent/JP4740999B2/ja active Active
- 2006-04-12 SI SI200632125A patent/SI1868622T1/sl unknown
- 2006-04-12 RU RU2007142174/13A patent/RU2378370C2/ru active
- 2006-04-12 WO PCT/SE2006/000434 patent/WO2006110088A1/en active Application Filing
- 2006-04-12 KR KR1020077021996A patent/KR101042123B1/ko active IP Right Grant
- 2006-04-12 MX MX2007012656A patent/MX2007012656A/es active IP Right Grant
- 2006-04-12 AU AU2006234793A patent/AU2006234793B2/en active Active
-
2007
- 2007-12-24 US US12/005,250 patent/US20080107635A1/en not_active Abandoned
-
2008
- 2008-05-26 HK HK08105855.5A patent/HK1115730A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008538288A5 (ja) | ||
| Huck et al. | Akkermansia muciniphila reduces Porphyromonas gingivalis‐induced inflammation and periodontal bone destruction | |
| US10449222B2 (en) | Method for preventing and/or treating infections, colonisations, or illnesses related to Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Enterococcus faecium, Enterobacter cloacae, Proteus mirabilis, Bacteroides fragilis, Staphylococcus epidermidis, Propionibacterium acnes, Candida albicans and/or Malassezia furfur | |
| KR101912380B1 (ko) | 프로바이오틱스의 방출 및 프로바이오틱스 효소 활성의 유지를 위한 점막점착성 장치 | |
| Arasu et al. | In vitro importance of probiotic Lactobacillus plantarum related to medical field | |
| JP5121715B2 (ja) | 保湿剤 | |
| JP2019520340A5 (ja) | ||
| JP2016529309A5 (ja) | ||
| JP2008501316A5 (ja) | ||
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| RU2010142003A (ru) | Синбиотическая смесь | |
| FI2839836T4 (fi) | Probiootit käytettäväksi vähennettäessä hengityselintaudin oireita | |
| JP2009539371A5 (ja) | ||
| CN104740138A (zh) | 包含芦荟、益生菌和益生元的组合物及其用途 | |
| RU2007142174A (ru) | Отбор и использование молочнокислых бактерий в целях снижения степени воспаления у млекопитающих | |
| CN1357038A (zh) | 乳酸细菌的组合及其用于预防和/或治疗感染和炎症的用途 | |
| JP6839329B2 (ja) | ヘリコバクター・ピロリ感染症の管理のための組成物 | |
| JP2019500056A5 (ja) | ||
| JP2018532034A (ja) | 機能性水和ヒアルロン酸及びこれを利用した優れた腸粘膜付着能及び選択的拮抗作用を有するコーティング乳酸菌の製造方法 | |
| EP2158916A1 (en) | Administration unit comprising lactic acid bacteria | |
| JP2017513906A (ja) | 炎症性腸疾患の治療に使用するための局所用組成物 | |
| WO2014154025A1 (zh) | 类黄酮在制药中的应用 | |
| JP2014500263A5 (ja) | ||
| JP2015180689A (ja) | 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置 | |
| WO2007071986A8 (en) | Use of whole bacterial cells (actinomycetales) for maternal administration to modulate offspring immune response |